Myeloid Heterogeneity in Kidney Disease as Revealed through Single-Cell RNA Sequencing

Area of Science:

• Immunology
• Nephrology
• Genomics

Background:

• Kidney disease is a growing global health concern and a significant risk factor for cardiovascular disease.
• Myeloid cells are integral to the immune system and play key roles in kidney injury, inflammation, and fibrosis.
• The plasticity and heterogeneity of myeloid cells in the kidney are complex and not fully understood.

Purpose of the Study:

• To review the roles of myeloid cells in kidney health and disease.
• To outline the experimental workflow of single-cell RNA sequencing (scRNA-seq) technologies.
• To summarize current findings on myeloid cells in kidney research using scRNA-seq.

Main Methods:

• Single-cell RNA sequencing (scRNA-seq) for high-resolution transcriptome analysis.
• Single-nuclear RNA sequencing (snRNA-seq) for studying cell-type-specific gene expression.
• Spatial transcriptomics for mapping cellular distribution within the kidney.

Main Results:

• scRNA-seq has transformed kidney research by enabling detailed analysis of single-cell transcriptomes.
• This technology facilitates the creation of comprehensive kidney cell atlases.
• scRNA-seq reveals the plasticity and heterogeneity of myeloid cells in kidney disease.

Conclusions:

• Advances in single-cell genomics, particularly scRNA-seq, are crucial for understanding kidney disease.
• Combining scRNA-seq with spatial transcriptomics will enhance the mapping of immune and nonimmune cells in kidney disease.
• Further research using these technologies will elucidate the complex roles of myeloid cells in renal pathophysiology.